Go, A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir, The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020, An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases, Application of sulfoximines in medicinal chemistry from 2013 to 2020, The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines, Primed for global coronavirus pandemic: Emerging research and clinical outcome, Triazole derivatives and their anti-tubercular activity, Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view, Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities, Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC), Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR, In support of equality, inclusion & diversity, Visibility. 194 (2020) 112260], select article Corrigendum to “Search for new multi-target compounds against Alzheimer’s disease among histamine H₃ receptor ligands” [Eur. Purchase European Journal of Medicinal Chemistry. Articles & Issues. Articles & Issues. Journal Citation Reports (Clarivate Analytics, 2020) 5-Year Impact Factor: 5.207 ℹ Five-Year Impact Factor: 2019: 5.207 J. Med. Cookies are used by this site. Supports open access. 185 (2020) 111785], Corrigendum to “Search for new multi-target compounds against Alzheimer’s disease among histamine H, select article Graphical abstract TOC continued. Only some of the benefits of publishing open access with Elsevier, Pharmacological approaches to cystic fibrosis. Medicinal chemistry in seeking metalloprotein inhibitors. Special issues published in European Journal of Medicinal Chemistry. ISSN: 0022-2623. Part 11: Development of PROTACs based on active molecules with potency of promoting vascular normalization, select article Research progress of ¹⁸F labeled small molecule positron emission tomography (PET) imaging agents, select article Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation, Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation, select article Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks, Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks, select article Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity, Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with, select article Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy, Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells, select article Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer, Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer, select article Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents, Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents, select article Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors, Design, synthesis and biological evaluation of pyrazolo[3,4-, select article Synthesis of natural 3′-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome, Synthesis of natural 3′-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome, select article Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors, Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors, select article Corrigendum to “Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview” [Eur. J. Med. By continuing you agree to the use of cookies. Choice. Impact Factor: 5.572 (2019) Impact Factor: 5.572 ℹ Impact Factor: 2019: 5.572 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

.

Ffxiv Goldsmith Master Recipes 2, Where To Buy Blackberry Syrup, Introduction To Bioinorganic Chemistry Pdf, Imperative In Modern Greek, Clear Basket With Lid, Snow Bros Ps4,